ARE Stock Forecast & Price Target

Alexandria Real Estate is attractive fundamentally because 2Q26 Core FFO per share of $1.73 beat both Citizens’ $1.59 estimate and the $1.64 consensus, while management still reaffirmed a $6.35-$6.45 full-year 2026 Core FFO per share range and preserved the $6.40 midpoint despite offsetting pressures from lower capitalized interest and higher interest expense. The company is also taking disciplined steps to improve future cash generation by re-evaluating 5 assets totaling 1.6M SF with a $1.4 billion book value, which should cut capex by $500 million, accelerate revenue recognition, and support a leaner development strategy while it continues pursuing $2.1-$3.7 billion of asset sales, including a greater mix of core assets via JVs. Although operating trends remain challenged by a 550 bps year-over-year occupancy decline and a 10.6% NOI drop amid elevated supply in key markets such as Greater Boston and South San Francisco, the stock’s positive outlook is anchored by its strong life science franchise, sustainability leadership, attractive valuation relative to peers, and meaningful upside if leasing conditions and supply absorption improve over time.

Alexandria Real Estate is facing a deteriorating fundamental backdrop driven by weakening occupancy and tenant retention, as same-property 2Q26 NOI fell 10.6% year-over-year and operating occupancy was only 86.9%, while management disclosed a known vacate expected to reduce NOI by about $100mm and roughly 1.5 million SF of move-outs in 2027. Its earnings trajectory is also under pressure, with core earnings now expected to drop 28.9% in 2026 and 17.9% in 2027, while guidance was tightened and adjusted for $10mm less straight-line rent revenue, $5mm lower capitalized interest, and $20mm more interest expense, all of which reflect a softer life science leasing environment and less supportive market conditions for new projects. Although liquidity remained $3.6B and debt maturity timing is manageable with only 6% due through 2028, leverage is elevated at 7.0x net debt to annualized Adjusted EBITDA in 2Q26 and could remain high even after the $1B of 7.25% junior subordinated notes, making dilution risk, asset sales, and slower NAV trends more likely to weigh on the common equity.